Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses

Hepatitis B and C viruses(HBV and HCV), both cause serious chronic infections leading to fatal liver diseases. The prototype therapy for both HBV and HCV was based on IFN-α with or without ribavirin. The advent of direct-acting antivirals(DAA) for both HBV and HCV has remarkably improved the standar...

Ausführliche Beschreibung